Podcast Index
Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.
Lung Cancer Update
Dr. Neil Love
Practical Advice from the Scriptures
Anissa Cooke
Nichful Thinking
Nichelle “Ohshells”
Spotlight 4 Success
American Book Company
Erotic Spirit Podcast
Erotic Spirit Podcast
7 Good Minutes
Clyde Lee Dennis
IELTS Band 9
IELTS Band 9
Shimon Davis
Shimon Davis
Healing TRAUMA
Kimberly's Hope LLC
On the Air
Becky Schoenfeld, W1BXY
Fifty Words For Snow
Maggie Rowe and Emily Garces
Dr. John Campbell
Campbellteaching
Audio-CD.at Indie Podcasts: Wiener Börse, Sport, Musik (und mehr)
Christian Drastil Comm. (Agentur für Investor Relations und Podcasts)
RadioSapienza
RadioSapienza
Your Quiet Moment
HavenMedia
UTN 2024
Juan Cruz Castro Molina
Look for the Good with Carrie Rowan
Carrie Rowan
Look for the Good with Carrie Rowan
Carrie Rowan
FRAU VERHANDELT - Gehaltsverhandlung für Frauen
Ljubow Strobel - Expertin für Gehaltsverhandlung
What Fulfills You?
Emily Elizabeth
The Fierce Female Network
Fierce Manson
Sunstone Mormon History Podcast
Sunstone
Fun Facts Daily
Kyle Wood
4 Min Rambam
Bnei Ruven
Curious Kids Every Day: A Daily Educational Podcast
Curious Kids Every Day
Start Your Day Positive
Len and Sara
Didi의 한국문화 Podcast (Korean Podcast)
Didi
Great Houses
Gregory Treat
Let´s Rock your Business
Judith Hoffmann
רק היום
דורון ליבשטיין וענת קלו לברון
Smash Boom Best: A funny, smart debate show for kids and family
Brains On Universe
The Partial Historians
The Partial Historians
鞠强教授：管理心理学
管理心理学教授鞠强
Documentaries
BBC
ADHD & Neurodiversity: The Spicy Brain Podcast
Megan Mioduski & Michelle Woodward
Life at Ten Tenths
Matt Bonelli and Garrett Frey
TED-Ed
TED-Ed
Educación
Dr. Neil Love
Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:Introduction (0:00)Overview of Antibody...
Featuring perspectives from Dr Lyudmila Bazhenova and Dr Corey J Langer, including the following topics: Introduction (0:00)Therapeutic Approaches Targeting HER2 and RET — Dr Bazhenova (9:09)Therapeutic Approaches Target...
Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics:Introduction (0:00)Current Management of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Dr Goldman (0:...
Featuring an interview with Prof Martin Reck, including the following topics:Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunothera...
Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding ...
Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported...
Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer. CME information and select publications...
Dr Hossein Borghaei from Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Anne Chiang from Yale Cancer Center in New Haven, Connecticut, discuss key clinical trial data in the first-line management of ES-SCL...
Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid and Dr Shields from Indiana University School of Medicine in Indianapolis discuss key datasets surrounding first-line and maintenance therapy ...
Dr Justin F Gainor, Dr Corey J Langer and Dr Misty Dawn Shields summarize the treatment landscape and review relevant clinical datasets for patients with lung cancer.CME information and select publications here.
Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer. CME information and se...
Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publ...
Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publi...
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. CME information and select publicati...
Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigational therapies for pat...
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and s...
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies fo...
Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as e...
Dr Anne Chiang, Dr Erin Schenk, and nurse practitioners Ms Elizabeth Krueger and Ms Beth Sandy discuss the role of bispecific antibodies in the management of small cell lung cancer and strategies to mitigate and manage t...
Prof Nicolas Girard, Dr Jonathan Goldman, Dr Pasi Jänne, Dr Suresh Ramalingam, Dr Joshua Sabari and moderator Dr Helena Yu present data informing treatment decision-making for EGFR-mutated NSCLC at the 2025 ASCO annual m...
Completa el formulario de abajo. Asegúrate de seleccionar tanto País como Géneros.
Envíanos un mensaje abajo. Te responderemos en un plazo de 24 horas.